Pneumothorax due to COVID-19: Analysis of case reports

Gaytán, David Alejandro Cabrera; Andrade, Yadira Pérez; Valenzo, Yuridia Espíritu

doi:10.1016/j.rmcr.2021.101490

Cited by 2 publications

(2 citation statements)

References 75 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 A higher SP proportion in males was also highlighted in studies on patients with SARS-CoV-2 infection. 6,7,9,11 Cigarette smoking is another acknowledged risk factor for developing SP-SPM. 1,24 In our study, 65% of the SP-SPM cases with no SARS-CoV-2 infection were active smokers.…”

Section: Discussionmentioning

confidence: 99%

“…8 Several reports showed a higher severity and worse outcome in patients with SP-SPM associated with SARS-CoV-2. 6,8,11 It correlated with the severity of lung damage, rather than with the magnitude of SP-SPM. [12][13][14] However, a multicenter retrospective case study by Martinelli et al 7 challenged these findings, reporting an overall survival rate of 63.1% in patients confirmed with COVID-19 and SP.…”

Section: Introductionmentioning

confidence: 94%

See 1 more Smart Citation

Risk Factors, Characteristics, and Outcome in Non-Ventilated Patients with Spontaneous Pneumothorax or Pneumomediastinum Associated with SARS-CoV-2 Infection

Marza¹,

Petrică²,

Lungeanu³

et al. 2022

IJGM

View full text Add to dashboard Cite

Background and Objectives: Spontaneous pneumothorax (SP) and spontaneous pneumomediastinum (SPM) have frequently been cited as complications associated with coronavirus disease 2019 (COVID-19) pneumonia, with especially poor prognosis in mechanically ventilated patients. The current literature is controversial regarding the potential risk factors for developing SP or SPM (SP-SPM) in non-ventilated COVID-19 patients. Our research addressed a twofold objective: (a) to investigate the characteristics of patients with SP-SPM (both with and without COVID-19) and compare them to patients with sole COVID-19; (b) to quantify the risk of in-hospital mortality associated with SP-SPM and COVID-19. Patients and Methods: A retrospective case-control study was conducted in the emergency departments (ED) of two tertiary hospitals in Timisoara, Romania, over one year (1st April 2020-31st March 2021; 64,845 records in total) and 70 cases of SP-SPM were identified (both SARS-CoV-2 positives and negatives). The control group comprised COVID-19 patients with no SP-SPM, included at a 2:1 ratio. Logistic regression was employed to quantify the in-hospital mortality risk associated with age, SP-SPM, and COVID-19. Results: SP-SPM and COVID-19 were connected with prolonged hospitalization, a higher percentage of intensive care admission, and a higher mortality. SP-SPM increased the odds of death by almost four times in patients of the same age, gender, smoking status, and SARS-CoV-2 infection: OR = 3.758, 95% CI (1.443-9.792). Each additional year of age added 9.4% to the mortality risk: OR = 1.094, 95% CI (1.054-1.135). Conclusion:ED physicians should acknowledge these potential risks when attending COVID-19 patients with SP-SPM.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 94%

Risk Factors, Characteristics, and Outcome in Non-Ventilated Patients with Spontaneous Pneumothorax or Pneumomediastinum Associated with SARS-CoV-2 Infection

Marza¹,

Petrică²,

Lungeanu³

et al. 2022

IJGM

View full text Add to dashboard Cite

show abstract

Pneumothorax in Intubated Patients With COVID-19: A Case Series

Chandna¹,

Colombo²,

Agrawal³

et al. 2022

Cureus

View full text Add to dashboard Cite

Pneumothorax is a rare complication among mechanically ventilated patients since low tidal volumes are used nowadays instead of traditional high tidal volumes, but the incidence is slightly higher in patients with high positive end-expiratory pressure (PEEP). Herein we describe a case series of nine patients who were on mechanical ventilation due to acute respiratory distress syndrome (ARDS) secondary to coronavirus disease 2019 (COVID-19) and developed pneumothorax in due course. A retrospective analysis was done on COVID-19 intubated patients from March 2020 to June 2020 in a community hospital in Central New Jersey, which was one of the early hit states in the United States at the beginning of the pandemic. Outcomes were studied. The demographics of patients like age, gender, and body mass index (BMI); risk factors like smoking, comorbidities especially chronic lung disease, and the treatment they received were compared. We compared the total number of days on the ventilator, the highest PEEP they received, and the ventilator day when pneumothorax developed. All the patients who developed pneumothorax had a chest tube inserted to treat it. The mortality was noted to be 100% indicating that pneumothorax is a life-threatening complication of COVID-19 and COVID-19 by itself is a risk factor for pneumothorax likely due to a change in lung mechanics. There is a need for large-scale studies to confirm that these outcomes are related to COVID-19.

show abstract

Pneumothorax due to COVID-19: Analysis of case reports

Cited by 2 publications

References 75 publications

Risk Factors, Characteristics, and Outcome in Non-Ventilated Patients with Spontaneous Pneumothorax or Pneumomediastinum Associated with SARS-CoV-2 Infection

Risk Factors, Characteristics, and Outcome in Non-Ventilated Patients with Spontaneous Pneumothorax or Pneumomediastinum Associated with SARS-CoV-2 Infection

Pneumothorax in Intubated Patients With COVID-19: A Case Series

Contact Info

Product

Resources

About